Back to top
more

Stereotaxis (STXS)

(Delayed Data from AMEX)

$1.87 USD

1.87
444,942

+0.03 (1.63%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $1.86 -0.01 (-0.53%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Stereotaxis Inc. (STXS) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of -16.67% and 19.05%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Orthofix (OFIX) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Orthofix (OFIX) delivered earnings and revenue surprises of 14.29% and 0.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Nevro (NVRO) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Nevro (NVRO) delivered earnings and revenue surprises of 12.35% and 0.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Veracyte (VCYT) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Veracyte (VCYT) delivered earnings and revenue surprises of 38.10% and 8.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Stereotaxis Inc. (STXS) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of 0% and 0.53%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Inari Medical, Inc. (NARI) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Inari Medical, Inc. (NARI) delivered earnings and revenue surprises of 25% and 4.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Semler Scientific Inc. (SMLR) Lags Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of -19.61% and 5.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Stereotaxis Inc. (STXS) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of -25% and 1.73%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

AxoGen (AXGN) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

AxoGen (AXGN) delivered earnings and revenue surprises of 38.46% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Stereotaxis Inc. (STXS) Q3 Earnings Expected to Decline

by Zacks Equity Research

Stereotaxis Inc. (STXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of 33.33% and 10.38%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Stereotaxis Inc. (STXS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

Stereotaxis Inc. (STXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why "Trend" Investors Would Love Betting on Stereotaxis Inc. (STXS)

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Stereotaxis Inc. (STXS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Stereotaxis Inc. (STXS) Soars 10%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Stereotaxis Inc. (STXS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

What Makes Stereotaxis Inc. (STXS) a Good Fit for "Trend Investing"

by Zacks Equity Research

Stereotaxis Inc. (STXS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Stereotaxis Inc. (STXS) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of 33.33% and 14.97%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Stereotaxis Inc. (STXS) Moves 13.6% Higher: Will This Strength Last?

by Zacks Equity Research

Stereotaxis Inc. (STXS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Stereotaxis Inc. (STXS) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of 0.00% and 15.68%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?